AR121608A1 - Cápsulas blandas de gel - Google Patents

Cápsulas blandas de gel

Info

Publication number
AR121608A1
AR121608A1 ARP210100679A ARP210100679A AR121608A1 AR 121608 A1 AR121608 A1 AR 121608A1 AR P210100679 A ARP210100679 A AR P210100679A AR P210100679 A ARP210100679 A AR P210100679A AR 121608 A1 AR121608 A1 AR 121608A1
Authority
AR
Argentina
Prior art keywords
soft gel
gel capsules
shell composition
solubilizes
certain embodiments
Prior art date
Application number
ARP210100679A
Other languages
English (en)
Inventor
Rickey Steve Shelley
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR121608A1 publication Critical patent/AR121608A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En determinadas realizaciones se divulga una cápsula blanda que comprende (a) un material de relleno; y (b) una composición de cubierta, donde el material de relleno comprende al menos el 10% de un medio líquido, y donde la composición de cubierta comprende gelatina y un polímero dependiente del pH que se solubiliza a un pH inferior a aproximadamente 6,0.
ARP210100679A 2020-03-18 2021-03-18 Cápsulas blandas de gel AR121608A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18

Publications (1)

Publication Number Publication Date
AR121608A1 true AR121608A1 (es) 2022-06-22

Family

ID=77771391

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100679A AR121608A1 (es) 2020-03-18 2021-03-18 Cápsulas blandas de gel

Country Status (11)

Country Link
US (1) US20230172864A1 (es)
EP (1) EP4121036A4 (es)
JP (1) JP2023518245A (es)
KR (1) KR20220154196A (es)
AR (1) AR121608A1 (es)
AU (1) AU2021238345A1 (es)
BR (1) BR112022018268A2 (es)
CA (1) CA3171512A1 (es)
CO (1) CO2022014130A2 (es)
MX (1) MX2022011549A (es)
WO (1) WO2021188773A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
JP2018514511A (ja) * 2015-04-14 2018-06-07 アトッサ ジェネティックス インク． 乳房障害とエストロゲン関連障害の処置のための組成物と方法
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
CN112105334B (zh) * 2018-03-15 2023-09-26 R.P.谢勒技术有限公司 肠溶性软明胶胶囊

Also Published As

Publication number Publication date
CA3171512A1 (en) 2022-09-23
CO2022014130A2 (es) 2022-10-31
EP4121036A4 (en) 2024-04-10
US20230172864A1 (en) 2023-06-08
KR20220154196A (ko) 2022-11-21
JP2023518245A (ja) 2023-04-28
MX2022011549A (es) 2022-10-13
WO2021188773A1 (en) 2021-09-23
BR112022018268A2 (pt) 2022-10-25
AU2021238345A1 (en) 2022-10-06
EP4121036A1 (en) 2023-01-25

Similar Documents

Publication Publication Date Title
Hegde et al. Sealing ability of a novel hydrophilic vs. conventional hydrophobic obturation systems: A bacterial leakage study
PE20001322A1 (es) Composicion multiparticula de liberacion modificada
BRPI0507320A (pt) máquina e método de enchimento de cápsula relacionada para produção de cápsulas vedadas
BRPI0517674B1 (pt) Sistema de cápsula mole de não-gelatina contendo amido modificado e carragenina com solução de enchimento de natureza básica
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
AR121608A1 (es) Cápsulas blandas de gel
MX2022013695A (es) Composicion encapsulada de microcapsulas de nucleo-cubierta y proceso para su preparacion.
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
HUP0104161A2 (hu) Javított stabilitású, peptidalapú trombin inhibitort tartalmazó injekciós oldatok és eljárás az előállításukra
AR119075A1 (es) Cápsulas blandas de liberación diferida
Turk et al. Effect of final irrigation procedures on fracture resistance of root filled teeth: an ex vivo study
AR124044A1 (es) Cápsulas blandas de liberación retardada
AR027748A1 (es) Pequenas esferas o globulos que contienen estavudina y permiten la liberacion controlada de la misma
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
AR114434A1 (es) Cápsulas de gelatina blanda entéricas
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
DK1028714T3 (da) Vitaminsammensætning
ATE392204T1 (de) Neue formulierungen für retinoid-haltige weichgelatinekapseln
BR112022024391A2 (pt) Cápsulas de gelatina mole para liberação retardada
Bachour et al. Evaluation of the rupture test for stability studies of soft-shell capsules
HUP9701112A2 (hu) Antiflatulenst tartalmazó töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
PT942702E (pt) Dispositivo de aprovisionamento de mechas medicinais
Pitout et al. Leakage of teeth root-filled with GuttaFlow and a single GP cone compared to lateral condensation and warm vertical condensation: scientific
CN207903055U (zh) 一种面膜包装结构
AR087032A1 (es) Composiciones de capsulas de gelatina y metodos para fabricarlas